Biologics Production Made Simple

An international team of scientists has developed a platform that allows for biologics production, analysis and assembly into functional complexes.

From Beer To Bispecifics And Beyond

Kiran Mazumdar-Shaw, chairman and managing director of Biocon, shares her thoughts on Asia’s growing role in biotech R&D.

Ambrx And BeiGene To Jointly Develop Next-Gen Biologics

Under the terms of the collaboration with BeiGene, Ambrx will receive US$10 million to fund the initial discovery and research activities for novel biologic drug candidates.

Merck Opens US$15 Million Lab In Singapore

The M Lab Collaboration Center will recreate actual manufacturing conditions for biologics and enhance biosafety testing.

WuXi To Establish Biologics Center In Northern China

The new biologics center in Shijiazhuang will include process development labs as well as clinical and commercial manufacturing facilities.

Cipla To Sell Two Roche Biologics In India

Cipla Ltd. and Roche Products (India) Private Limited have signed a distribution agreement for the promotion and sale of tocilizumab and bevacizumab.

BeiGene Receives US$320 Million To Build Biologics Facility In China

BeiGene Co. Ltd. and Guangzhou Development District have entered into a joint venture worth US$330 million to build a state-of-the-art biologics manufacturing plant.

WuXi Acquires Biologics CRO HD Biosciences

WuXi AppTec strengthens its biologics capabilities with its acquisition of Shanghai-based HD Biosciences.

Takeda Invests US$125 Million In Maverick’s T-Cell Platform

Maverick Therapeutics Inc. and Takeda will collaborate to develop a biologics platform for T-cell immunotherapy over the next five years.

Takeda & PvP Biologics To Develop Drugs Against Celiac Disease

Takeda Pharmaceuticals and PvP Biologics have signed an agreement to develop therapeutics targeting celiac disease.